Clinical Study
Ranibizumab for Visual Impairment due to Diabetic Macular Edema: Real-World Evidence in the Italian Population (PRIDE Study)
Table 2
Number of ranibizumab treatments received during the 18-month follow-up period.
| |||||||||||||||||||||
DME, diabetic macular edema; SD, standard deviation. |